GH1 and Cirrhosis: High GH levels were associated with advanced disease and poor clinical outcome including more frequent cirrhosis, poorly differentiated tumors, multi-nodularity, vascular invasion, higher α-fetoprotein (AFP) levels, and advanced clinicopathological staging (Table 1).